Will health be good for your wealth?

Set up your individual savings account now and you can maximise your returns

With six months left to invest this year's tax-free allowance of £7,000 in an individual savings account (ISA), you may be thinking that you've got plenty of time to get round to it.

With six months left to invest this year's tax-free allowance of £7,000 in an individual savings account (ISA), you may be thinking that you've got plenty of time to get round to it.

But it is worth remembering that, statistically, those investors who put regular amounts into an ISA over the year get better returns. And those who buy their ISAs on the eve of the 5 April deadline get less for their money as the price is inflated by the surge of interest from other investors.

So with this in mind, which funds are attracting investors this year? Technology remains popular, despite the volatility of the sector (see opposite page). But healthcare is predicted to be the big growth story this year and in the future.

Much of this interest is down to the success of the project to map the human genome (the blueprint for the established 200,000 different genes that create a human being), which was finished several years ahead of schedule. Drugs can now be tailored to individuals to make them more effective. Biotechnology and healthcare are undeniably highly speculative, but just think what would happen to the share price of a company that discovered a cure for cancer.

"Unlike dot coms, these companies are creating tangible, sellable products," says Donna Bradshaw, director at independent financial adviser (IFA) Fiona Price & Partners. "There is quite a lot of confidence in the sector, although it is not for the faint-hearted."

While general European and North American ISAs often have some exposure to biotech and medical companies, specialist healthcare funds are being launched in response to increased demand. Unfortunately, as some of these funds are so new, they have no track record.

"You can't say with a new fund how good the performance is going to be," says Ms Bradshaw. "It might be worth taking a punt. But you should do a lot of homework, look at the underlying investments and bear in mind how long the manager has studied this type of investment."

Framlington Healthcare is one of the best-established funds in the sector. It was launched in 1987 and its manager, Antony Milford, has been involved with the fund since then.

"In this particular sector, that expertise is very important," says Framlington's marketing manager, Lesley Hankin. "[The sector] is hugely specialised and he knows it inside out and backwards."

The fund is available as an ISA, and has £400m in assets under management. But even though it is long-established, it is highly volatile. In the past 12 months (to year ending 1 September), however, it rose by 228.2 per cent, topping the specialist fund sector, according to Money Management magazine.

Fidelity Investments has just launched four new funds concentrating on different sectors, one of which invests in healthcare (the others are financial, industrial and consumer). Brigitte Ascher, fund analyst at Fidelity, believes that the healthcare industry has great growth potential for investors. "It is expected to increase its revenues due to the fact that the population is ageing," she says. "Older people need more drugs and more looking after from a healthcare point of view, so spending will continue to rise."

Ms Ascher also points out that the discovery of blockbuster, or money-making, drugs is expected to increase over the next few years, with quite a few currently in the pipeline. According to figures from Merrill Lynch, a total of seven block-buster drugs will be launched this year, doubling to 14 next year and 17 the year after.

The fragmentation of the healthcare sector, coupled with the rising costs of research and development, means that there are also likely to be a number of mergers in the industry - which can be good news for investors.

When Glaxo Smith-Kline completes its merger, becoming the biggest pharmaceutical company in the world, it will still capture just 7 per cent of the overall market, with many much smaller companies having a tiny stake.

Depending on their exposure to biotechnology, some funds are riskier than others. Investors should look at their underlying investments carefully. Framlington Healthcare, for example, opts for big pharmaceutical firms and invests only partly in biotechnology stocks. The Schroder Medical Discovery fund opts for mainly healthcare with a few biotech companies thrown in, as does Flemings' Global Life Sciences. Franklin Biotechnology, available from Edinburgh-based fund manager Templeton, invests exclusively in biotech.

Whichever fund you choose, bear in mind that it should form only part of your overall portfolio because of the high-risk factor. Only if you have a broad spread of investments in other sectors and countries, should you look at healthcare, and even then, you should be prepared to tie your money up for 10 years or so.

"Keep your head on your shoulders and don't get carried away with short-term gains," says Ms Bradshaw. "Then you won't make the mistake people did with technology, in going for the fast buck. It is wise to keep the bulk of your money in less speculative funds."

* Contacts: Fidelity, 0800 414161; Flemings, 0500 500324; Framlington Group, 0345 775511; Schroders, 0800 718777; Templeton, 0131 228 3932.

Independent Partners; Do you need financial advice on your investments, pension or insurance? Book a free consultation with an independent Financial Adviser at VouchedFor.co.uk

Life and Style
food + drink
Life and Style
love + sex A new study has revealed the average size - but does that leave men outside the 'normal' range being thought of as 'abnormal'?
Life and Style
Tikka Masala has been overtaken by Jalfrezi as the nation's most popular curry
food + drink
News
UK Border Control
i100
Finacial products from our partners
Property search
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

ES Rentals

    iJobs Job Widget
    iJobs Money & Business

    Christine McCleave: FP&A Analyst

    £36,000 - £40,000: Christine McCleave: Are you looking for a new opportunity a...

    Recruitment Genius: Sales Executive - OTE £40,000

    £15000 - £18000 per annum: Recruitment Genius: This is a great opportunity for...

    Austen Lloyd: Law Costs HOD - Southampton

    £50000 - £60000 per annum + Excellent Salary: Austen Lloyd: An outstanding new...

    SThree: Recruitment Resourcer

    £20000 - £21000 per annum + uncapped commission: SThree: As a graduate you are...

    Day In a Page

    Syrian conflict is the world's first 'climate change war', say scientists, but it won't be the last one

    Climate change key in Syrian conflict

    And it will trigger more war in future
    How I outwitted the Gestapo

    How I outwitted the Gestapo

    My life as a Jew in wartime Berlin
    The nation's favourite animal revealed

    The nation's favourite animal revealed

    Women like cuddly creatures whilst men like creepy-crawlies
    Is this the way to get young people to vote?

    Getting young people to vote

    From #VOTESELFISH to Bite the Ballot
    Poldark star Heida Reed: 'I don't think a single bodice gets ripped'

    Poldark star Heida Reed

    'I don't think a single bodice gets ripped'
    The difference between America and Israel? There isn’t one

    The difference between America and Israel? There isn’t one

    Netanyahu knows he can get away with anything in America, says Robert Fisk
    Families clubbing together to build their own affordable accommodation

    Do It Yourself approach to securing a new house

    Community land trusts marking a new trend for taking the initiative away from developers
    Head of WWF UK: We didn’t send Cameron to the Arctic to see green ideas freeze

    David Nussbaum: We didn’t send Cameron to the Arctic to see green ideas freeze

    The head of WWF UK remains sanguine despite the Government’s failure to live up to its pledges on the environment
    Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

    Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

    Set in a mythologised 5th-century Britain, ‘The Buried Giant’ is a strange beast
    With money, corruption and drugs, this monk fears Buddhism in Thailand is a ‘poisoned fruit’

    Money, corruption and drugs

    The monk who fears Buddhism in Thailand is a ‘poisoned fruit’
    America's first slavery museum established at Django Unchained plantation - 150 years after slavery outlawed

    150 years after it was outlawed...

    ... America's first slavery museum is established in Louisiana
    Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

    Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

    The first 'American Idol' winner on how she manages to remain her own woman – Jane Austen fascination and all
    Tony Oursler on exploring our uneasy relationship with technology with his new show

    You won't believe your eyes

    Tony Oursler's new show explores our uneasy relationship with technology. He's one of a growing number of artists with that preoccupation
    Ian Herbert: Peter Moores must go. He should never have been brought back to fail again

    Moores must go. He should never have been brought back to fail again

    The England coach leaves players to find solutions - which makes you wonder where he adds value, says Ian Herbert
    War with Isis: Fears that the looming battle for Mosul will unleash 'a million refugees'

    The battle for Mosul will unleash 'a million refugees'

    Aid agencies prepare for vast exodus following planned Iraqi offensive against the Isis-held city, reports Patrick Cockburn